ID    AVR/I/SSAP239
ET    Non-clinical
PN    C14-LK
PL    16 [Note: any special compound, if present in sequence, is not considered in length]
SR    Not available
SO    Synthetic peptide
TX    Not available
VL    Experimentally validated
XX
TO    VISA-31
IC    MIC = 12.5 microM
TH    Strong hemolytic effect on human erythrocytes
XR    PubMed: 34360692
XR    RCSB PDB/PDBsum/PDBe/PDBj/PDBe-KB/MMDB: Not available 
XR    UniProt: Not available
XR    DrugBank: Not available
XX
SQ    SEQUENCE  
      C14-RW 
//

